Skip to main content
OpenTrials

Clinical trial condition

Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)

Explore clinical trials studying Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II) trial results

Completed

Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma

NCT01582776

Conditions
Follicular Lymphoma Patients (Phase IB), Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • A.Z. Sint Jan AV Bruges, Belgium
  • institut Jules Bordet Brussels, Belgium
  • Université Catholique de Louvain Saint Luc Brussels, Belgium
View all 25 locations
View Trial Details

Related conditions